These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31002010)

  • 1. A Newborn with Congenital Hyperinsulinism.
    Du Y; Ju R; Xi Y; Gou P
    Fetal Pediatr Pathol; 2019 Oct; 38(5):406-411. PubMed ID: 31002010
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital hyperinsulinism due to compound heterozygous mutations in ABCC8 responsive to diazoxide therapy.
    Taylor-Miller T; Houghton J; Munyard P; Kumar Y; Puvirajasinghe C; Giri D
    J Pediatr Endocrinol Metab; 2020 May; 33(5):671-674. PubMed ID: 32267248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutation c.597_598dup in exon 5 of ABCC8 gene causing congenital hyperinsulinism.
    Jindal R; Ahmad A; Siddiqui MA; Kochar IS; Wangnoo SK
    Diabetes Metab Syndr; 2014; 8(1):45-7. PubMed ID: 24661758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservatively treated Congenital Hyperinsulinism (CHI) due to K-ATP channel gene mutations: reducing severity over time.
    Salomon-Estebanez M; Flanagan SE; Ellard S; Rigby L; Bowden L; Mohamed Z; Nicholson J; Skae M; Hall C; Craigie R; Padidela R; Murphy N; Randell T; Cosgrove KE; Dunne MJ; Banerjee I
    Orphanet J Rare Dis; 2016 Dec; 11(1):163. PubMed ID: 27908292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoallelic ABCC8 mutations are a common cause of diazoxide-unresponsive diffuse form of congenital hyperinsulinism.
    Saint-Martin C; Zhou Q; Martin GM; Vaury C; Leroy G; Arnoux JB; de Lonlay P; Shyng SL; Bellanné-Chantelot C
    Clin Genet; 2015 May; 87(5):448-54. PubMed ID: 24814349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Management and Gene Mutation Analysis of Children with Congenital Hyperinsulinism in South China.
    Xu A; Cheng J; Sheng H; Wen Z; Lin Y; Zhou Z; Zeng C; Shao Y; Li C; Liu L; Li X
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):400-409. PubMed ID: 31208162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of ABCC8 and clinical manifestations in eight Chinese children with hyperinsulinemic hypoglycemia.
    Chang G; Ying L; Zhang Q; Feng B; Yao R; Ding Y; Li J; Huang X; Shen Y; Yu T; Wang J; Wang X
    BMC Endocr Disord; 2024 Jan; 24(1):8. PubMed ID: 38212772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine in Congenital Hyperinsulinism - A Case Report.
    Khawash P; Hussain K; Flanagan SE; Chatterjee S; Basak D
    J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):151-4. PubMed ID: 26316440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemic hypoglycemia evolving to gestational diabetes and diabetes mellitus in a family carrying the inactivating ABCC8 E1506K mutation.
    Vieira TC; Bergamin CS; Gurgel LC; Moisés RS
    Pediatr Diabetes; 2010 Nov; 11(7):505-8. PubMed ID: 20042013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital Hyperinsulinism Caused by Novel Homozygous KATP Channel Gene Variants May Be Linked to Unexplained Neonatal Deaths among Kurdish Consanguineous Families.
    Amaratunga SA; Hussein Tayeb T; Rozenkova K; Kucerova P; Pruhova S; Lebl J
    Horm Res Paediatr; 2020; 93(1):58-65. PubMed ID: 32203961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide-related exocrine pancreatic insufficiency (EPI) in congenital hyperinsulinism.
    Ros-Pérez P; Golmayo L; Cilleruelo ML; Gutiérrez C; Celaya P; Lacámara N; Martínez-Badás I; Güemes M; Argente J
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):947-950. PubMed ID: 32634108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic characterization of congenital hyperinsulinism in Spain.
    Martínez R; Fernández-Ramos C; Vela A; Velayos T; Aguayo A; Urrutia I; Rica I; Castaño L;
    Eur J Endocrinol; 2016 Jun; 174(6):717-26. PubMed ID: 27188453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization and Management of Congenital Hyperinsulinism: A Tertiary Centre Experience.
    Sharma R; Roy K; Satapathy AK; Kumar A; Nanda PM; Damle N; Houghton JAL; Flanagan SE; Radha V; Mohan V; Jain V
    Indian Pediatr; 2022 Feb; 59(2):105-109. PubMed ID: 34992182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and management of neonatal onset hyperinsulinemic hypoglycemia: a single neonatal center experience.
    Bezirganoglu H; Okur N; Celik K; Tas FF; Ozbek MN
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2272014. PubMed ID: 37860935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.
    Raicevic M; Milenkovic T; Hussain K; Djordjevic M; Martic J; Todorovic S; Mitrovic K; Sarajlija A; Vukovic R
    Eur J Pediatr; 2021 Sep; 180(9):2815-2821. PubMed ID: 33770274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and treatment response to diazoxide in two siblings with congenital hyperinsulinism as a result of a novel compound heterozygous ABCC8 missense mutation.
    Galcheva S; Iotova V; Ellard S; Flanagan SE; Halvadzhiyan I; Petrova C; Hussain K
    J Pediatr Endocrinol Metab; 2017 Apr; 30(4):471-474. PubMed ID: 28328534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, outcome, and predictors of neurological sequelae of persistent congenital hyperinsulinism: A single tertiary center experience.
    Laimon W; Aboelenin HM; El Tantawi NT
    Pediatr Diabetes; 2021 May; 22(3):388-399. PubMed ID: 33528087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide-associated cholestasis and hepatitis in an infant with congenital hyperinsulinism.
    Levy-Khademi F; Irina S; Avnon-Ziv C; Levmore-Tamir M; Leder O
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):449-51. PubMed ID: 25324442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.